About the company
Zoetis, a leading animal health company, is dedicated to providing a comprehensive range of pharmaceutical products and solutions for animals. With a diverse portfolio that includes anti-infectives, vaccines, parasiticides, diagnostics, and other health products, Zoetis plays a pivotal role in ensuring the well-being of both production animals and companion animals. The company's revenue streams are well-balanced, with slightly less than half of its total revenue coming from production animals and the remaining portion generated by companion animal products. This strategic segmentation allows Zoetis to serve a wide range of customers, from large-scale livestock producers to pet owners. In the United States, Zoetis has a strong emphasis on companion animals, which include dogs, horses, and cats. The company has built a solid reputation in this segment, offering innovative solutions for the health and well-being of pets. Whether it is vaccines to protect against common diseases, diagnostics to aid in early detection, or anti-infectives to treat infections, Zoetis is committed to enhancing the quality of life for companion animals. On the international front, Zoetis' business is slightly more geared towards production animals. This global perspective enables the company to address the unique challenges faced by livestock farmers and producers worldwide. Zoetis understands the significance of maintaining healthy herds and flocks, and provides a wide range of products to prevent and treat various diseases, ensuring the productivity and sustainability of the industry. As the largest market player in the industry, Zoetis has a significant market share, allowing it to exert a substantial influence on the animal health sector. With a strong presence in both the production animal and companion animal segments, Zoetis has established itself as a trusted partner for veterinarians, livestock producers, and pet owners. The roots of Zoetis can be traced back to its previous affiliation with Pfizer, where it served as Pfizer's animal health unit. However, in 2013, Zoetis became an independent company, tailoring its expertise and resources solely to the animal health market. This strategic separation allowed Zoetis to focus exclusively on developing innovative solutions and advancing veterinary medicine, while leveraging its deep industry knowledge and extensive research capabilities. Today, Zoetis continues to prioritize research and development, investing in cutting-edge technologies and scientific advancements. By collaborating with veterinary professionals and institutions worldwide, Zoetis remains at the forefront of the industry, constantly striving to improve animal health outcomes and contribute to a sustainable future for animals and the people who care for them. In conclusion, Zoetis stands as a leader in the animal health industry, offering a wide range of products and solutions for both production animals and companion animals. With a strong market presence and a commitment to innovation, Zoetis plays a crucial role in advancing veterinary medicine, promoting animal welfare, and supporting the livelihoods of those involved in animal agriculture and pet care.
Website: https://www.zoetis.com
Data updated: June 2, 2026
